跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nostero - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nostero
Approved
STANDARD
Nostero
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
adcc0b9fae3ad09d
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
adcc0b9fae3ad09d
Drug Approval Philippines Name
Nostero
Product Name
Nostero
Registration Number
DRP-11803
Brand Name
Nostero
Generic Name
Phenylpropanolamine Hydrochloride/Brompheniramine Maleate
Dosage Form
Syrup (Drops)
Dosage Strength
6.25mg / 2mg per mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
J.M. Tolmann Laboratories, Inc.
Issuance Date
29 April 2022
Expiry Date
07 September 2026
Pharmacologic Category
Decongestant/Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
adcc0b9fae3ad09d
Type
Standard
Back to Philippines FDA Approvals